Global Blood Screening Market Segments 2024, Forecast To 2033
5 Mar, 2024
The blood screening market has shown strong growth, increasing from $2.84 billion in 2023 to $3.13 billion in 2024, achieving a CAGR of 10.0%. Contributing factors include increased blood transfusion requirements, rising prevalence of transmissible diseases, government regulations and standards, increasing blood donations and collection, and global health concerns and pandemics. Expecting rapid growth, the market is forecasted to reach $4.72 billion in 2028, maintaining a CAGR of 10.9%. The growth in the forecast period can be attributed to healthcare infrastructure development, public health awareness programs, advancements in infectious disease diagnostics, and global health concerns and pandemic preparedness. Major trends include a rise in infectious diseases, automation and efficiency, rising blood transfusion demands, focus on transfusion safety, and research in pathogen detection.
Global Blood Screening Market Key Driver
The blood screening market is set to grow with the increasing prevalence of infectious diseases. Tuberculosis claimed approximately 1.6 million lives in 2021, and malaria cases rose to 241 million, indicating a critical need for blood screening to prevent further disease spread, as reported by the World Health Organization.
Get A Free Sample Of The Global Blood Screening Market ReportGlobal Blood Screening Market Segments
The blood screening market covered in this report is segmented –
1) By Product: Reagents and Kits, Instruments, Software and Services
2) By Technology: Nucleic Acid Testing, Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Tests, Western Blot Assays, Next-Generation Sequencing (NGS)
3) By End User: Blood Banks, Diagnostic Centers and Pathology Labs, Hospitals, Clinics, Ambulatory Surgical Centers (ASCs)
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the blood screening market in 2023. The regions covered in the blood screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Blood Screening Industry Players
Abbott Laboratories; Grifols S.A.; Becton Dickinson and Company; F. Hoffmann-La Roche AG; bioMérieux S.A.; Bio-Rad Laboratories Inc.; Thermo Fisher Scientific Inc.; Ortho Clinical Diagnostics Inc.; Beckman Coulter Inc.; Siemens Healthineers AG; GE Healthcare; DiaSorin S.p.A.; Merck KGaA; PerkinElmer Inc.; Bio-Techne Corporation; Roche Diagnostics GmbH; Danaher Corporation; Sysmex Corporation; Natera Inc.; GenMark Diagnostics Inc.; QIAGEN N.V.; Hologic Inc.; Luminex Corporation; Trinity Biotech plc; Fujirebio Inc.; OraSure Technologies Inc.; Immunetics Inc.; Accelerate Diagnostics Inc.; Cepheid Inc.; T2 Biosystems Inc.; Haemonetics Corporation; HTG Molecular Diagnostics Inc.; Verax Biomedical Inc.
Get The Full Global Blood Screening Market Report
AIOps Blood Screening Market Overview
Blood screening refers to a method of screening blood, plasma, or blood components for transfusion or use in blood products. It is used to screen for antibodies or tumor markers, to seek for disease-causing substances or symptoms, or to evaluate treatment effectiveness.
Blood Screening Global Market Report 2023 provides data on the global blood screening market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The blood screening market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.